CRIM1-b-Catenin-Cadherin Interactions in Eye Development and Disease
CRIM1-b-连环蛋白-钙粘蛋白在眼睛发育和疾病中的相互作用
基本信息
- 批准号:7843631
- 负责人:
- 金额:$ 37.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-01 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAdhesionsAdhesivenessAdultAge related macular degenerationBindingBiochemical GeneticsBiologicalBiological AssayBiological ModelsBudgetsCadherinsCataractCell AdhesionCellsComplexCrystalline LensCytoskeletonDataDefectDevelopmentDiabetic RetinopathyDiseaseDown-RegulationEpithelialEpithelial CellsEpitheliumEquilibriumEyeEye DevelopmentFetal DevelopmentGeneticGenetic ModelsGoalsInfectionIntegral Membrane ProteinLeadLearningLeftLigand BindingLigandsMediatingMethodsModelingMorphogenesisMusMutant Strains MiceNeoplasm MetastasisOrganismPhosphorylationProcessPublic HealthRecombinant ProteinsRegulationRelative (related person)RoleStagingStudy SubjectSystemTimeVascular DiseasesVascular Endothelial CellWorkbasebeta catenincadherin 5designepithelial to mesenchymal transitionexperiencein vivoinnovationinterestlenslens morphogenesisneoplastic cellnovel therapeuticsprotein protein interactionstoichiometrytooltumortumor progression
项目摘要
Our long-term goal is an understanding of the mechanisms of lens development. In this application, our more restricted goal is to determine how the unusual transmembrane protein CRIM1 mediates epithelial adhesion and morphogenesis in the developing lens. Our preliminary analysis has shown that CRIM1 regulates cell adhesion through interactions with beta-catenin and cadherins. CRIM1 can form a complex with b-catenin which in turn interacts with cadherins. Our central hypothesis is that through complex formation with catenins and cadherins, CRIM1 regulates epithelial cell adhesion and morphogenesis. To investigate the function of CRIM1 in the lens, we propose two specific aims: Aim 1. To determine the mechanism of interaction between CRIM1, beta-catenin and cadherins. With interaction assays that are cell-based or recombinant protein-based we will determine whether CRIM1 binds beta-catenin with any of the known ligand binding mechanisms. This will include an assessment of the role of phosphorylation as this is known to influence binding of other beta-catenin ligands. We will also determine the stoichiometry of CRIM1-beta-catenin/cadherin complexes as this may have important biological implications. Aim 2. To determine whether the CRIM1-beta-catenin interaction regulates cadherin-dependent adhesion in the lens. Using forms of CRIM1 that either cannot or obligatorily interact with beta-catenin we will determine, using rescue of CRIM1 conditionally mutant mice, whether the CRIM1-beta-catenin interaction is important for cadherin dependent adhesion in the developing lens. The study of developmental morphogenesis is interesting in its own right but also has important consequences for our understanding of disease. For example, regulation of cadherin adhesiveness is critical for eye-specific diseases such as secondary cataract formation where there is an epithelial to mesenchymal transition and in the vascular diseases diabetic retinopathy and age-related macular degeneration that require the modulation of VE-cadherin in vascular endothelial cells. The down-regulation of cadherin expression and activity is also know to be a critical step in epithelial tumor progression as it allows tumor cells to leave the epithelium, become invasive and ultimately form metastases.
我们的长期目标是了解晶状体发育的机制。在此应用中,我们更严格的目标是确定不寻常的跨膜蛋白 CRIM1 如何介导发育中晶状体的上皮粘附和形态发生。我们的初步分析表明 CRIM1 通过与 β-连环蛋白和钙粘蛋白的相互作用来调节细胞粘附。 CRIM1 可以与 β-连环蛋白形成复合物,而 β-连环蛋白又与钙粘蛋白相互作用。我们的中心假设是,通过与连环蛋白和钙粘蛋白形成复合物,CRIM1 调节上皮细胞粘附和形态发生。为了研究 CRIM1 在晶状体中的功能,我们提出了两个具体目标: 目标 1. 确定 CRIM1、β-连环蛋白和钙粘蛋白之间相互作用的机制。通过基于细胞或重组蛋白的相互作用测定,我们将确定 CRIM1 是否通过任何已知的配体结合机制结合 β-连环蛋白。这将包括对磷酸化作用的评估,因为已知磷酸化会影响其他 β-连环蛋白配体的结合。我们还将确定 CRIM1-β-连环蛋白/钙粘蛋白复合物的化学计量,因为这可能具有重要的生物学意义。目标 2. 确定 CRIM1-β-连环蛋白相互作用是否调节晶状体中钙粘蛋白依赖性粘附。使用不能或必须与β-连环蛋白相互作用的CRIM1形式,我们将通过拯救CRIM1条件突变小鼠来确定CRIM1-β-连环蛋白相互作用对于发育中的晶状体中的钙粘蛋白依赖性粘附是否重要。发育形态发生的研究本身就很有趣,而且对我们对疾病的理解也有重要影响。例如,钙粘蛋白粘附性的调节对于眼睛特异性疾病至关重要,例如继发性白内障形成,其中存在上皮到间质的转变,以及血管疾病糖尿病性视网膜病和年龄相关性黄斑变性,这些疾病需要调节血管中的VE-钙粘蛋白内皮细胞。钙粘蛋白表达和活性的下调也被认为是上皮肿瘤进展的关键步骤,因为它允许肿瘤细胞离开上皮,变得具有侵袭性并最终形成转移。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RASHMI S. HEGDE其他文献
RASHMI S. HEGDE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RASHMI S. HEGDE', 18)}}的其他基金
A ROLE FOR EYA3 IN VASCULAR REMODELING AND PULMONARY ARTERIAL HYPERTENSION
EYA3 在血管重塑和肺动脉高压中的作用
- 批准号:
10412990 - 财政年份:2020
- 资助金额:
$ 37.34万 - 项目类别:
A ROLE FOR EYA3 IN VASCULAR REMODELING AND PULMONARY ARTERIAL HYPERTENSION
EYA3 在血管重塑和肺动脉高压中的作用
- 批准号:
10171900 - 财政年份:2020
- 资助金额:
$ 37.34万 - 项目类别:
A ROLE FOR EYA3 IN VASCULAR REMODELING AND PULMONARY ARTERIAL HYPERTENSION
EYA3 在血管重塑和肺动脉高压中的作用
- 批准号:
10657352 - 财政年份:2020
- 资助金额:
$ 37.34万 - 项目类别:
Linked regulation of tumor angiogenesis and chemo-resistance
肿瘤血管生成和化疗耐药的关联调节
- 批准号:
9306421 - 财政年份:2017
- 资助金额:
$ 37.34万 - 项目类别:
Linked regulation of tumor angiogenesis and chemo-resistance
肿瘤血管生成和化疗耐药的关联调节
- 批准号:
10248475 - 财政年份:2017
- 资助金额:
$ 37.34万 - 项目类别:
Eyes Absent phosphatase inhibitors in eye disease
眼睛 眼病中缺乏磷酸酶抑制剂
- 批准号:
7888260 - 财政年份:2009
- 资助金额:
$ 37.34万 - 项目类别:
CRIM1-b-Catenin-Cadherin Interactions in Eye Development and Disease
CRIM1-b-连环蛋白-钙粘蛋白在眼睛发育和疾病中的相互作用
- 批准号:
7573094 - 财政年份:2009
- 资助金额:
$ 37.34万 - 项目类别:
Eyes Absent phosphatase inhibitors in eye disease
眼睛 眼病中缺乏磷酸酶抑制剂
- 批准号:
7657586 - 财政年份:2009
- 资助金额:
$ 37.34万 - 项目类别:
相似国自然基金
人胎盘水凝胶类器官贴片重建子宫内膜对重度宫腔粘连的作用及机制研究
- 批准号:
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:
促细胞外囊泡分泌的绒毛膜纳米纤维仿生培养体系的构建及其在宫腔粘连修复中的应用研究
- 批准号:32301204
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
负载羟基喜树碱的双层静电纺纳米纤维膜抑制肌腱粘连组织增生的作用和相关机制研究
- 批准号:82302691
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ROS清除型动态粘附水凝胶的制备及其在声带粘连防治中的作用与机制研究
- 批准号:82301292
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于“胞宫藏泻”理论探讨补肾养营活血方和HuMSCs调节ERS介导的细胞焦亡重塑粘连宫腔内膜容受态的研究
- 批准号:82305302
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Full Project 1: Defining Mechanisms of MICAL-dependent Pancreatic Cancer Cell Migration
完整项目 1:MICAL 依赖性胰腺癌细胞迁移的定义机制
- 批准号:
10762273 - 财政年份:2023
- 资助金额:
$ 37.34万 - 项目类别:
Project 1: Defining Mechanisms of MICAL-dependent Pancreatic Cancer Cell Migration
项目 1:定义 MICAL 依赖性胰腺癌细胞迁移机制
- 批准号:
10762144 - 财政年份:2023
- 资助金额:
$ 37.34万 - 项目类别:
Dysregulation of Platelet-von Willebrand Factor Interaction in Trauma-Induced Coagulopathy
创伤性凝血病中血小板-血管性血友病因子相互作用的失调
- 批准号:
10352212 - 财政年份:2020
- 资助金额:
$ 37.34万 - 项目类别:
Dysregulation of Platelet-von Willebrand Factor Interaction in Trauma-Induced Coagulopathy
创伤性凝血病中血小板-血管性血友病因子相互作用的失调
- 批准号:
10559557 - 财政年份:2020
- 资助金额:
$ 37.34万 - 项目类别:
Local Regulation of Angiogenesis by Microenvironment
微环境对血管生成的局部调节
- 批准号:
10376043 - 财政年份:2020
- 资助金额:
$ 37.34万 - 项目类别: